Meclofenoxate

Chemical formula: C₁₂H₁₆ClNO₃  Molecular mass: 257.082 g/mol  PubChem compound: 4039

Therapeutic indications

Meclofenoxate is indicated for:

Cerebral aging

Population group: only adults (18 years old or older)

Senile degeneration of brain

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Cerebral atherosclerosis

Population group: only adults (18 years old or older)

Cerebral atherosclerosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Neurological or psychological sequelea of head injury

Population group: only adults (18 years old or older)

Neurological or psychological sequelea of head injury; manifesting by: mental deterioration; mental fatigue & inability to concentrate, disturbed memory and mood, intellectual impairment and behavioral changes. Neurological symptoms; Transient neurological attacks, paresis of face and limbs, Visual disturbance, Vertigo & tinnitus, Motor & sensory aphasia.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Meclofenoxate is contraindicated in the following cases:

Pronounced condition of excitement

at least one of
Excitement
Uncontrollable excitement

Citicoline

Citicoline

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.